71
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Gastroprotective effects of amifostine in rats treated by T-2 toxin

, , , , , , & show all
Pages 123-127 | Received 01 Nov 2016, Accepted 08 May 2017, Published online: 25 May 2017
 

Abstract

Cytoprotector amifostine (AMI) was given in a dose of 50, 100 or 150 mg/kg ip in rats treated with several highly toxic doses of T-2 toxin. The best survival rate (24 h and 7 days after treatment) was obtained with AMI50 (50 mg/kg ip). After T-2 intoxication, a peak in the mean number of gastric lesions (petechiae and ulcerations) was reached on the third day (26.40 ± 6.24). Administration of AMI50 reduced, almost completely, the total number of gastric lesions in rats acutely poisoned by 0.5 LD50 T-2 (1.5 mg/kg sc), starting with day 1 after intoxication (5.60 ± 3.42).

Acknowledgements

This work received partial financial support from the Ministry of Education, Science and Technological Development of the Republic of Serbia, and from the Ministry of Defense of the Republic of Serbia. This work was also supported by long-term development plan UHK and UHHK of the Czech Republic.

Declaration of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,628.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.